Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Multicenter Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes

NCT00803530 is registered in ClinicalTrials.gov with Fondazione Italiana Sindromi Mielodisplastiche-ETS as lead sponsor.

NCT NCT00803530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00803530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Multicenter Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
Lead sponsor
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2005
Completion date
August 31, 2010
Enrollment
55 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndromes